April 05, 2020

Public health policies

The International Agency for Research on Cancer (IARC), a division of the World Health Organization, conducted a review of carcinogenic risks of combined hormonal contraceptives (CHC) and combine menopausal treatments in 2005 and concluded that both are in Group I, the highest classification of carcinogenicity. CHC were put on this list in 1992. The information can be found by going to the WHO Web site www.who.int/en/ and the following links: Health Topics-Cancer-Reproductive Health and Research Center-Publications and Documents: 2005 Carcinogenicity of Combined Hormonal Treatment and Combined Meno-pausal Treatment.

Worldwide, more than 100 million women, about 10 percent of all women of reproductive age, use combined hormonal contraceptives. Just like cigarette smoking, another preventable form of cancer, not all will develop the disease. However, there is no way of predicting which ones will – therefore, all are at elevated risk.

In 2003, the National Cancer Institute has found a significant increase incident in breast, cervical, and liver cancers. For every 100 U.S. women, 28 will have breast cancer and three will have ovarian cancer.

In 1970, one in 12 women developed breast cancer, not it is one in seven. The third annual AIDS Conference stated that oral contraceptive users appear to be “less resistant to AIDS than nonusers.” They destroy a women’s natural immunity to STDs, and numerous studies document a great number of other diseases and complications that are linked with the use of artificial steroid-loaded pills.

Doesn’t it make you wonder about our public health policies? Let us work to educate the public and enact public health policies that truly reflect known medical science.

Jean Barry


Have feedback? Want to know more? Send us ideas for follow-up stories.

comments for this post are closed

You may also like